Study identifies pandemic-related stressor in Parkinson’s diseaseSeptember 23, 2021Parkinson's DiseaseCOVID-19 UpdatesMovement Disorders
Investigative botulinum toxin formulation shows prolonged effectSeptember 23, 2021Movement DisordersNeuromuscular Disorders
Efforts target underrepresented populations in Parkinson’s disease genetic studiesSeptember 23, 2021Parkinson's DiseaseMovement Disorders
Surge in new-onset tics in adults tied to COVID-19 stressSeptember 22, 2021Movement DisordersCOVID-19 Updates
Sublingual film well tolerated for Parkinson ‘off’ episodesSeptember 21, 2021Parkinson's DiseaseMovement Disorders
Friedreich’s ataxia treatment shows extended benefitSeptember 21, 2021Rare DiseasesMovement Disorders
Survey identifies clinicians’ unease with genetic testingSeptember 21, 2021Parkinson's DiseaseGene TherapyMovement Disorders
Toward ‘superhuman cognition’: The future of brain-computer interfacesSeptember 3, 2021Parkinson's DiseaseMovement Disorders
Nonmotor symptoms common in Parkinson’sAugust 26, 2021Movement DisordersParkinson's DiseaseSleep MedicineAlzheimer's & Cognition
Anxiety, inactivity linked to cognitive impairment in Parkinson’sAugust 24, 2021Movement DisordersParkinson's Disease
Psychotic features among older adults tied to Parkinson’sAugust 23, 2021Movement DisordersParkinson's Disease
Increased risk of hospitalization and death with Parkinson’s drugAugust 19, 2021Parkinson's DiseaseMovement Disorders
Trauma, psychiatric comorbidities tied to functional motor disordersJuly 23, 2021Movement DisordersTrauma
Hearing loss tied to decline in physical functioningJuly 2, 2021Alzheimer's & CognitionMovement Disorders
Guidance provided for telepsychiatry in tardive dyskinesiaJune 25, 2021Movement DisordersBusiness of MedicineCOVID-19 Updates
